{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:33:26Z","timestamp":1772156006467,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/pas.0b013e3181c5e26b","type":"journal-article","created":{"date-parts":[[2009,12,21]],"date-time":"2009-12-21T10:46:44Z","timestamp":1261392404000},"page":"75-87","source":"Crossref","is-referenced-by-count":158,"title":["Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm\u2014Morphologic and Phenotypic Variability in a Series of 33 Patients"],"prefix":"10.1097","volume":"34","author":[{"given":"Carlo","family":"Cota","sequence":"first","affiliation":[]},{"given":"Esmeralda","family":"Vale","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Viana","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Requena","sequence":"additional","affiliation":[]},{"given":"Gerardo","family":"Ferrara","sequence":"additional","affiliation":[]},{"given":"Lucia","family":"Anemona","sequence":"additional","affiliation":[]},{"given":"Dieter","family":"Metze","sequence":"additional","affiliation":[]},{"given":"Regina","family":"Fink-Puches","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Wiesner","sequence":"additional","affiliation":[]},{"given":"Lorenzo","family":"Cerroni","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-9-20210131","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00277-001-0380-0","article-title":"Blastic NK-cell lymphoma\/leukemia with T-cell receptor gamma rearrangement","volume":"80","author":"Aoyama","year":"2001","journal-title":"Ann Hematol"},{"key":"R2-9-20210131","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1080\/10428190410001723232","article-title":"Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature","volume":"45","author":"Argyrakos","year":"2004","journal-title":"Leukem Lymph"},{"key":"R3-9-20210131","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1600-0560.2007.00915.x","article-title":"CD4-negative variant of CD4+\/CD56+ hematodermic neoplasm: description of three cases","volume":"35","author":"Ascani","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R4-9-20210131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jcp.2006.042135","article-title":"CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer","volume":"60","author":"Assaf","year":"2007","journal-title":"J Clin Pathol"},{"key":"R5-9-20210131","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","article-title":"CD56+ hematological neoplasms presenting in the skin a retrospective analysis of 23 new cases and 130 cases from the literature","volume":"15","author":"Bekkenk","year":"2004","journal-title":"Ann Oncol"},{"key":"R6-9-20210131","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0190-9622(90)70055-M","article-title":"Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: a comparative study","volume":"22","author":"Cerroni","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"R7-9-20210131","first-page":"191","article-title":"Skin Lymphoma. The Illustrated Guide. 3rd ed","author":"Cerroni","year":"2009"},{"key":"R8-9-20210131","first-page":"214","article-title":"WHO Classification of Tumors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Chan","year":"2001"},{"key":"R9-9-20210131","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","article-title":"Identification of a leukemic counterpart of the plasmacytoid dendritic cells","volume":"97","author":"Chaperot","year":"2001","journal-title":"Blood"},{"key":"R10-9-20210131","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2006-04-018143","article-title":"Gene-expression profiling and array-based CGH classify CD4CD56 hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities","volume":"109","author":"Dijkman","year":"2007","journal-title":"Blood"},{"key":"R11-9-20210131","first-page":"145","article-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"Facchetti","year":"2008"},{"key":"R12-9-20210131","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3324\/haematol.13855","article-title":"Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm","volume":"94","author":"Facchetti","year":"2009","journal-title":"Haematologica"},{"key":"R13-9-20210131","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","article-title":"Clinical and biologic features of CD4+ CD56+ malignancies","volume":"99","author":"Feuillard","year":"2002","journal-title":"Blood"},{"key":"R14-9-20210131","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":"Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia","volume":"145","author":"Garnache-Ottou","year":"2009","journal-title":"Br J Haematol"},{"key":"R15-9-20210131","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/FY6PK436NBK0RYD4","article-title":"CD4+\/CD56+ hematodermic tumor. The features of an evolving entity and its relationship to dendritic cells","volume":"127","author":"Herling","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R16-9-20210131","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.3800679","article-title":"Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms","volume":"19","author":"Jaye","year":"2006","journal-title":"Mod Pathol"},{"key":"R17-9-20210131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2133.2004.06296.x","article-title":"CD56-negative blastic natural killer-cell lymphoma (agranular CD4+\/CD56+ haematodermic neoplasm)?","volume":"152","author":"Kawai","year":"2005","journal-title":"Br J Dermatol"},{"key":"R18-9-20210131","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1365-2133.2003.05639.x","article-title":"Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukemia: a coincidence or more?","volume":"149","author":"Kazakov","year":"2003","journal-title":"Br J Dermatol"},{"key":"R19-9-20210131","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/cncr.10489","article-title":"CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia","volume":"94","author":"Khoury","year":"2002","journal-title":"Cancer"},{"key":"R20-9-20210131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ajh.20001","article-title":"Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement","volume":"75","author":"Liu","year":"2004","journal-title":"Am J Hematol"},{"key":"R21-9-20210131","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2007-10-117531","article-title":"Novel markers of normal and neoplastic human plasmacytoid dendritic cells","volume":"111","author":"Marafioti","year":"2008","journal-title":"Blood"},{"key":"R22-9-20210131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.pas.0000126719.71954.4f","article-title":"Subcutaneous, blastic natural killer (NK), NK\/T-cell, and other cytotoxic lymphomas of the skin. A morphologic, immunophenotypic, and molecular study of 50 patients","volume":"28","author":"Massone","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R23-9-20210131","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.0022-202X.2005.23617.x","article-title":"CD4+ CD56+ blastic tumor cells express CD101 molecules","volume":"124","author":"Meyer","year":"2005","journal-title":"J Invest Dermatol"},{"key":"R24-9-20210131","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0145-2126(01)00198-9","article-title":"Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic-cell precursor origin: two cases","volume":"26","author":"Momoi","year":"2002","journal-title":"Leuk Res"},{"key":"R25-9-20210131","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2001.19.8.2179","article-title":"Natural killer\/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course","volume":"19","author":"Mraz-Gernhard","year":"2001","journal-title":"J Clin Oncol"},{"key":"R26-9-20210131","first-page":"143","article-title":"Primary cutaneous CD4+\/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases","volume":"91","author":"Ng","year":"2006","journal-title":"Haematologica"},{"key":"R27-9-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5858\/2007-131-149-ACHNAD","article-title":"Agranular CD4\/CD56 Hematodermic Neoplasm A Distinct Entity Described in the Recent World Health Organization-European Organization for Research and Treatment of Cancer Classification for Cutaneous Lymphomas","volume":"131","author":"Niakosari","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R28-9-20210131","first-page":"161","article-title":"Skin manifestations in CD4+, CD56+ malignancies","volume":"13","author":"Penven","year":"2003","journal-title":"Eur J Dermatol"},{"key":"R29-9-20210131","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/00000478-200207000-00003","article-title":"Agranular CD4+ CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes","volume":"26","author":"Petrella","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R30-9-20210131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1309\/0QPPAVTUPCV9UCLV","article-title":"TCL1 and CLA expression in agranular CD4\/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis","volume":"122","author":"Petrella","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R31-9-20210131","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2004.05713.x","article-title":"A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+\/CD56+ haematodermic neoplasm)","volume":"150","author":"Petrella","year":"2004","journal-title":"Br J Dermatol"},{"key":"R32-9-20210131","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":"Blastic NK-cell Lymphomas (agranular CD4+CD56+ hematodermic neoplasms). A review","volume":"123","author":"Petrella","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R33-9-20210131","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1309\/W9Q5AGYDE5LANN39","article-title":"CD4+\/CD56+ hematodermic neoplasm (\u201cblastic natural killer cell lymphoma\u201d). Neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon","volume":"128","author":"Pilichowska","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R34-9-20210131","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000172194.32918.5c","article-title":"CD4+ CD56+ lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells","volume":"29","author":"Reichard","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R35-9-20210131","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1600-0560.2007.00845.x","article-title":"CD4+\/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement","volume":"35","author":"Stetsenko","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R36-9-20210131","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/cncr.21268","article-title":"Blastic natural killer cell lymphoma\/leukemia (CD56-positive blastic tumor). Prognostication and categorization according to anatomic sites of involvement","volume":"104","author":"Suzuki","year":"2005","journal-title":"Cancer"},{"key":"R37-9-20210131","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"R38-9-20210131","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO- European Organization for the Research and Treatment of Cancer classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000478-201001000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T05:52:03Z","timestamp":1634363523000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201001000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e3181c5e26b","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1884970.1432068","asserted-by":"object"}]},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}